Cargando…
Six months response rate of combined oral medroxyprogesterone/levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study
OBJECTIVE: To evaluate the efficacy of combined oral medroxyprogesterone acetate (MPA)/levonorgestrel-intrauterine system (LNG-IUS) treatment and to compare the diagnostic accuracy of endometrial aspiration biopsy with dilatation & curettage (D&C) in young women with early-stage endometrial...
Autores principales: | Kim, Mi Kyoung, Seong, Seok Ju, Kang, Soon-Beom, Bae, Duk-Soo, Kim, Jae-Weon, Nam, Joo-Hyun, Lim, Myong Cheol, Lee, Taek Sang, Kim, Sunghoon, Paek, Jiheum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393640/ https://www.ncbi.nlm.nih.gov/pubmed/30740964 http://dx.doi.org/10.3802/jgo.2019.30.e47 |
Ejemplares similares
-
Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia
por: Behnamfar, Fariba, et al.
Publicado: (2014) -
Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases
por: Kim, Mi-La, et al.
Publicado: (2013) -
Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression
por: Morrison, Charles S., et al.
Publicado: (2020) -
Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant
por: Deese, Jennifer, et al.
Publicado: (2021) -
Fertility-Sparing Treatment for Endometrial Cancer: Oncological and Obstetric Outcomes in Combined Therapies with Levonorgestrel Intrauterine Device
por: Pino, Ida, et al.
Publicado: (2022)